Emmaus Life Sciences, Inc. (EMMA)

OTCMKTS · Delayed Price · Currency is USD

0.0150

+0.0020 (15.38%)

Apr 2, 2026, 1:03 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals		16.65M	29.60M	18.39M	20.61M	23.17M
Pharmaceuticals Growth		-43.73%	60.94%	-10.77%	-11.04%	1.82%
Total		16.65M	29.60M	18.39M	20.61M	23.17M
Total Growth		-43.73%	60.94%	-10.77%	-11.04%	1.82%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States		13.48M	22.00M	-	-	-
United States Growth		-38.73%	-	-	-	-
International		2.67M	6.96M	-	-	-
International Growth		-61.67%	-	-	-	-
Other		506.00K	636.00K	-	-	-
Other Growth		-20.44%	-	-	-	-
Total		16.65M	29.60M	-	-	-
Total Growth		-43.73%	-	-	-	-

Source: S&P Global Market Intelligence.